发明名称 |
PHARMACEUTICAL COMPOSITION FOR A HEPATITIS C VIRAL PROTEASE INHIBITOR |
摘要 |
<p>Disclosed is a pharmaceutical composition of a hepatitis C viral protease inhibitor which is suitable for oral administration via a liquid- or semi-solid-filled capsule and methods of using this composition for inhibiting the replication of the hepatitis C virus (HCV) and for the treatment of an HCV infection. The liquid- or semi-solid pharmaceutical composition of the present invention comprises a compound of formula I, or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable lipids and hydrophilic surfactants.</p> |
申请公布号 |
EP2451438(B8) |
申请公布日期 |
2014.04.09 |
申请号 |
EP20100731685 |
申请日期 |
2010.07.01 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
CHEN, FENG-JING;SCHWABE, ROBERT J. |
分类号 |
A61K9/107;A61K9/48;A61K31/427;A61K47/10;A61K47/12;A61K47/14;A61K47/44 |
主分类号 |
A61K9/107 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|